Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Molecular biological aspect]

T Shimazui1

  • 1Dept. of Urology, Institute of Clinical Medicine, University of Tsukuba.

Gan to Kagaku Ryoho. Cancer & Chemotherapy
|June 9, 1998
PubMed
Summary

Prostate cancer research highlights genetic alterations like 8p LOH in early stages and AR gene variations linked to cancer risk and treatment resistance. Molecular diagnostics like PSM-RT-PCR show promise for detecting disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Decreased expression of CXXC4 promotes a malignant phenotype in renal cell carcinoma by activating Wnt signaling.

Oncogene·2008
Same author

Promoting effects of antiandrogenic agents on rat ventral prostate carcinogenesis induced by 3,2'-dimethyl-4-aminobiphenyl (DMAB).

Prostate cancer and prostatic diseases·2002
Same author

[A case of transitional cell carcinoma of the urinary bladder with high serum level of CEA and CA19-9].

Hinyokika kiyo. Acta urologica Japonica·2001
Same author

AgNOR count in resting cells (resting NOR) is a new prognostic marker in invasive bladder tumor.

Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology·2001
Same author

Genetic heterogeneity of surgically resected prostate carcinomas and their biopsy specimens is related to their histologic differentiation.

Cancer·2001
Same author

Classical cadherins in urological cancers.

Morphologie : bulletin de l'Association des anatomistes·2000

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Context:

  • Prostate adenocarcinoma is a growing concern in Japanese men, with many etiological and pathological questions remaining.
  • Genetic alterations are key to understanding prostate cancer development, but frequent changes are not yet identified.

Purpose:

  • To review current knowledge on prostate cancer genetics, focusing on genetic alterations, androgen receptor (AR) gene, and molecular diagnostics.
  • To explore the significance of specific genetic events like 8p LOH and 17p alterations in prostate carcinogenesis.
  • To discuss the role of the AR gene in treatment resistance and cancer risk, and the potential of novel diagnostic markers.

Summary:

  • Loss of heterozygosity (LOH) on 8p is implicated in early prostate carcinogenesis, while 17p alterations are considered late events.
  • Androgen receptor (AR) gene mutations can lead to resistance to androgen blockade therapy and anti-androgen withdrawal syndrome.
  • Shorter CAG repeats in the AR gene are associated with an increased risk of prostate cancer.
  • Prostate-specific membrane antigen (PSM) and its RT-PCR assay show potential for sensitive and specific detection of micrometastatic disease, possibly outperforming PSA-RT-PCR.

Impact:

  • Identifies key genetic markers for prostate cancer development and risk stratification.
  • Highlights the importance of AR gene status in predicting treatment response and understanding resistance mechanisms.
  • Introduces PSM-RT-PCR as a promising tool for early and accurate diagnosis of metastatic prostate cancer.
  • Suggests that ongoing research into gene therapy may offer future treatment avenues.

Related Experiment Videos